Close the acquisition of Exact Sciences Corporation
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 20 Nov 2025
- Due
- 30 Jun 2026
- Delivered
- 23 Mar 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The closing is expected in the second quarter of 2026 and is subject to Exact Sciences’ shareholder approval”
What we found
Evidence strength A What the grades mean
Abbott completed the Exact Sciences acquisition on March 23, 2026, before the end-of-Q2 2026 deadline, as stated in later 10-Q and 8-K filings.
-
A Abbott Laboratories 10-Q filed 2026-04-29
“On March 23, 2026, Abbott completed the acquisition of Exact Sciences Corporation (Exact Sciences).” ✓ confirmed on the page
-
A Abbott Laboratories 10-Q filed 2026-07-28
“On March 23, 2026, Abbott completed the acquisition of Exact Sciences Corporation (Exact Sciences).” ✓ confirmed on the page
-
A Abbott Laboratories 10-Q filed 2026-07-28
“The Exact Sciences acquisition was completed on March 23, 2026, and its results are reported within the Diagnostic Products segment as Cancer Diagnostics from the date of acquisition.” ✓ confirmed on the page
Market reaction: the shares moved -5.9% against the S&P 500 over the three sessions around the disclosure (28 Apr 2026 to 1 May 2026). What this measures
Checked 10 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- Acquisition of Exact Sciences Corporation
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Low
- Specificity
- Medium
- Conditional
- Yes: subject to Exact Sciences' shareholder approval; receipt of applicable regulatory approvals; other customary closing conditions
- Depends on
- Shareholder, Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Abbott Laboratories? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-ABT-006039 · Corrections policy